Malignant Colorectal Neoplasm — Trials

Malignant Colorectal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,565
Recruiting: 883
Ph III recruiting: 104
Growth YoY: +13.3%
Industry share: 22%
Top sponsor: Fudan University
Termination share: 25.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (722)

clinicaltrialsPublishedShowing 851–900 of 1,137 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06949982	Efficacy And Safety Of Hydroxychloroquine Combined With Methotrexate, Capecitabine And Bevacizumab Vs. Regorafenib In Participants With Refractory Metastatic Colorectal Cancer With Mutations In RAS Genes(x-МАР)	recruiting	Phase 2	60	Sergey Orlov, MDOTHER	1	May 4, 2025	clinicaltrials
NCT06307938	Circulating Tumor DNA in Patients Summoned for Colonoscopy; - a Liquid Biopsy for Detection, Characterization, Individualized Treatment and Follow-up of Colorectal Cancer(CoLiQ)	recruiting	—	3,000	Helse Nord-Trøndelag HF